MedPath

Soonchunhyang University Hospital

🇰🇷South Korea
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

58

Active:0
Completed:30

Trial Phases

4 Phases

Phase 1:1
Phase 2:8
Phase 4:5
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (32 trials with phase data)• Click on a phase to view related trials

Not Applicable
18 (56.3%)
Phase 2
8 (25.0%)
Phase 4
5 (15.6%)
Phase 1
1 (3.1%)

Tegoprazan and Amoxicillin Dual Therapy

Recruiting
Conditions
H.Pylori Infection
First Posted Date
2025-04-30
Last Posted Date
2025-04-30
Lead Sponsor
Soonchunhyang University Hospital
Target Recruit Count
50
Registration Number
NCT06950489
Locations
🇰🇷

Digestive Disease Center, Soonchunhyang University Hospital, Seoul, Korea, Republic of

RUT vs. Molecular Testing for H. Pylori

Recruiting
Conditions
H.Pylori Infection
First Posted Date
2024-11-12
Last Posted Date
2025-04-29
Lead Sponsor
Soonchunhyang University Hospital
Target Recruit Count
100
Registration Number
NCT06684860
Locations
🇰🇷

Digestive Disease Center, Soonchunhyang University Hospital, Seoul, Korea, Republic of

Tegoprazan- Versus PPI-based H. Pylori Eradication

Recruiting
Conditions
H.Pylori Infection
First Posted Date
2024-11-12
Last Posted Date
2025-04-29
Lead Sponsor
Soonchunhyang University Hospital
Target Recruit Count
200
Registration Number
NCT06682533
Locations
🇰🇷

Digestive Disease Center, Soonchunhyang University Hospital, Seoul, Korea, Republic of

Immunologic Changes and Recovery-related Factors in Elderly Colon Cancer Patients

Phase 2
Completed
Conditions
Cancer of Colon
Interleukins
Aged
First Posted Date
2024-06-12
Last Posted Date
2024-06-12
Lead Sponsor
Soonchunhyang University Hospital
Target Recruit Count
75
Registration Number
NCT06454071
Locations
🇰🇷

Soonchunhyang University Hospital, Seoul, Korea, Republic of

Comparison of Twice- and Four-times-daily Amoxicillin Administration in 2-week Tegoprazan-based H. Pylori Eradication

Completed
Conditions
H.Pylori Infection
Interventions
First Posted Date
2024-05-29
Last Posted Date
2025-04-30
Lead Sponsor
Soonchunhyang University Hospital
Target Recruit Count
100
Registration Number
NCT06431737
Locations
🇰🇷

Soonchunhyang University Hospital, Seoul, Korea, Republic of

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.